Showing results (151-160 of 156) with videos related to
Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 156 results.
Lancet (London, England)|September 21, 2025
Minimum effective low dose of antithymocyte globulin in people aged 5-25 years with recent-onset stage 3 type 1 diabetes (MELD-ATG): a phase 2, multicentre, double-blind, randomised, placebo-controlled, adaptive dose-ranging trialChantal Mathieu, Julie Wych, A Emile J Hendriks, et al.Diabetes/Metabolism Research and Reviews|July 4, 2024
Multi-omics analysis reveals drivers of loss of β-cell function after newly diagnosed autoimmune type 1 diabetes: An INNODIA multicenter studyJose Juan Almagro Armenteros, Caroline Brorsson, Christian Holm Johansen, et al.Diabetes Care|November 23, 2019
Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 DiabetesManuela Battaglia, Simi Ahmed, Mark S Anderson, et al.Nature Immunology|October 21, 2010
A model for harmonizing flow cytometry in clinical trialsHolden T Maecker, J Philip McCoy, , et al.European Journal of Immunology|December 15, 2021
Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)Andrea Cossarizza, Hyun-Dong Chang, Andreas Radbruch, et al.European Journal of Immunology|October 22, 2019
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)Andrea Cossarizza, Hyun-Dong Chang, Andreas Radbruch, et al.Pageof 16